Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)
2020 · Kidney International Reports · 121 citations
https://doi.org/10.1016/j.ekir.2020.03.030
H
Hironori Kanda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
668
Citations
14
h-index
14
i10-index
Hironori Kanda is an academic researcher from Kyowa Kirin (Japan). The author has contributed to research in topics: Parathyroid Disorders and Treatments & Mercury impact and mitigation studies & Potassium and Related Disorders. The author has an h-index of 14, co-authored 22 publications.
Papers by this author
worksEffect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients
2021 · Kidney International Reports · 17 citations
https://doi.org/10.1016/j.ekir.2021.06.030
In Reply to “Letter Regarding ‘Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial’”
2022 · Kidney International Reports · 0 citations
https://doi.org/10.1016/j.ekir.2022.05.023
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat